{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:12Z","timestamp":1761870672131,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clml.2014.12.010","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T12:26:54Z","timestamp":1420806414000},"page":"e121-e125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report and Review of Immunodeficiency-Associated Burkitt Lymphoma"],"prefix":"10.1016","volume":"15","author":[{"given":"Daniel H.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2014.12.010_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X","article-title":"Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden","volume":"73","author":"Cot\u00e9","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clml.2014.12.010_bib2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jcp.2007.051953","article-title":"HIV infection and lymphoma","volume":"60","author":"Grogg","year":"2007","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clml.2014.12.010_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","article-title":"AIDS-associated non-Hodgkin lymphoma","volume":"337","author":"Beral","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2014.12.010_bib4","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/asheducation-2008.1.341","article-title":"Burkitt lymphoma in adults","volume":"2008","author":"Perkins","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2014.12.010_bib6","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","article-title":"How I treat HIV associated lymphoma","volume":"119","author":"Dunleavy","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/apc.2007.0124","article-title":"Improving outcomes for patients with Burkitt lymphoma and HIV","volume":"22","author":"Blinder","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.clml.2014.12.010_bib8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0002-9343(01)01020-8","article-title":"Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes","volume":"111","author":"Gabarre","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.clml.2014.12.010_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification","volume":"2011","author":"Jaffe","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2014.12.010_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.6004\/jnccn.2012.0155","article-title":"NCCN clinical practice guidelines\u00a0in\u00a0oncology, non-Hodgkin's lymphomas","volume":"10","author":"Zelenetz","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clml.2014.12.010_bib11","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood.V79.5.1282.1282","article-title":"Histogenetic correlations between subcategories of small noncleaved cell lymphomas","volume":"79","author":"Yano","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2014.12.010_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/1042819031000141301","article-title":"Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity","volume":"45","author":"Lacasce","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2014.12.010_bib14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.3673.3673","article-title":"Feasibility and toxicity of a modified dose intensive R- CODOX-M\/IVAC for HIV-associated Burkitt and atypical Burkitt lymphoma (BL): preliminary results of a prospective multicenter phase II trial of the AIDS malignancy consortium (AMC)","volume":"114","author":"Noy","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdh262","article-title":"Treatment of Burkitt's\/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens","volume":"15","author":"Smeland","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2014.12.010_bib16","doi-asserted-by":"crossref","first-page":"735392","DOI":"10.1155\/2012\/735392","article-title":"HIV-associated Burkitt lymphoma: good efficacy and tolerance of intensive chemotherapy including CODOX-M\/IVAC with or without rituximab in the HAART era","volume":"2012","author":"Rodrigo","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.clml.2014.12.010_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cncr.23522","article-title":"High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma","volume":"113","author":"Oriol","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.12.010_bib18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.12.010_bib19","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection","volume":"336","author":"Kaplan","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.12.010_bib20","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0000000000000133","article-title":"HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era","volume":"28","author":"Coutinho","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.clml.2014.12.010_bib22","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib23","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/cncr.26723","article-title":"Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma","volume":"118","author":"Barta","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.12.010_bib24","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with\u00a0cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus\u2013associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.12.010_bib26","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2014.12.010_bib27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2014.12.010_bib28","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood-2008-03-145128","article-title":"A\u00a0prospective clinicopathologic study of dose-modified CODOX-M\/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC\/NCRI LY10 trial)","volume":"112","author":"Mead","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib29","first-page":"858","article-title":"Efficacy and toxicity of rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or Burkitt-like leukemia\/lymphoma: Cancer and Leukemia Group B (CALGB) study 10002","volume":"116","author":"Rizzieri","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.12.010_bib30","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V99.8.2685","article-title":"Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy","volume":"99","author":"Wilson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib31","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.12.010_bib32","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt's lymphoma","volume":"369","author":"Dunleavy","year":"2013","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014005461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014005461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:20Z","timestamp":1761870380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265014005461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2152265014005461"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2014.12.010","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case Report and Review of Immunodeficiency-Associated Burkitt Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}